RIKEN-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:RIKEN - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013523
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
RIKEN is a research organization, which carries out research in basic and applied sciences. Its research system consists of strategic research centers, research infrastructure centers, chief scientist system, etc. and a cluster for industry partnerships. Its centers, laboratories and research facilities collaborate and support each other to enhance the outcomes. The organization’s research spans the entire range of natural sciences, from developmental biology and neuroscience to quantum physics, computer science and green innovation. It also enters into external collaboration and works in partnership with private companies to transform its scientific developments into commercial products. The organization operates through facilities in Wako, Tsukuba, Yokohama, Kobe and Harima. RIKEN is headquartered in Wako, Saitama, Japan.

RIKEN – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
RIKEN, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
RIKEN, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
RIKEN, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
RIKEN, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
RIKEN, Medical Devices Deals, 2011 to YTD 2017 9
RIKEN, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
RIKEN, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Center for iPS Cell Research and Application, Takeda Pharma and RIKEN Enter into Partnership 11
Santen Pharma Enters into Research Agreement with Riken and Foundation for Biomedical Research and Innovation 12
RIKEN and Otsuka Pharma Forms Joint Venture 13
Shin Nippon Biomedical Labs Enters Into Research Agreement With Riken 14
Riken Enters Into Agreement With Takeda Pharma To Form Riken Bsi-Takeda Collaboration Center 15
RIKEN Brain Science Enters Into Research Collaboration With Astellas Pharma 16
Licensing Agreements 17
Vedanta Biosciences Enters into Licensing Agreement with Riken, University of Tokyo, and Azabu University 17
Mitsubishi Chemical Medience Enters Into Licensing Agreement With Shimadzu And Riken 18
RIKEN – Key Competitors 19
RIKEN – Key Employees 20
RIKEN – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 23
Government and Public Interest 23
Jan 20, 2016: Study results leading to the development of a new type of anticancer agent 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
RIKEN, Pharmaceuticals & Healthcare, Key Facts 2
RIKEN, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
RIKEN, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
RIKEN, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
RIKEN, Deals By Therapy Area, 2011 to YTD 2017 8
RIKEN, Medical Devices Deals, 2011 to YTD 2017 9
RIKEN, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Center for iPS Cell Research and Application, Takeda Pharma and RIKEN Enter into Partnership 11
Santen Pharma Enters into Research Agreement with Riken and Foundation for Biomedical Research and Innovation 12
RIKEN and Otsuka Pharma Forms Joint Venture 13
Shin Nippon Biomedical Labs Enters Into Research Agreement With Riken 14
Riken Enters Into Agreement With Takeda Pharma To Form Riken Bsi-Takeda Collaboration Center 15
RIKEN Brain Science Enters Into Research Collaboration With Astellas Pharma 16
Vedanta Biosciences Enters into Licensing Agreement with Riken, University of Tokyo, and Azabu University 17
Mitsubishi Chemical Medience Enters Into Licensing Agreement With Shimadzu And Riken 18
RIKEN, Key Competitors 19
RIKEN, Key Employees 20
RIKEN, Subsidiaries 21

★海外企業調査レポート[RIKEN-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Myers Industries Inc (MYE):企業の財務・戦略的SWOT分析
    Summary Myers Industries Inc (Myers) is a chemical company that manufactures and distributes plastic and rubber products. The company offers plastic storage containers, rubber tire repair products, custom plastic and rubber products, tire balancers and tire retread products. It also provides materia …
  • Aiful Corp:企業の戦略・SWOT・財務分析
    Aiful Corp - Strategy, SWOT and Corporate Finance Report Summary Aiful Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • DIA Imaging Analysis Ltd:医療機器:M&Aディール及び事業提携情報
    Summary DIA Imaging Analysis Ltd (DIA Imaging Analysis), formerly DiACardio Ltd is a provider of medical imaging solutions. The company’s products comprise LVivo SWM, LVivo EF, and LVivo Strain. Its LVivo SWM is a fully automated echo device or PACS systems. DiACardio’s LVivo platform comprises tool …
  • Berliner Volksbank eG:企業の戦略・SWOT・財務情報
    Berliner Volksbank eG - Strategy, SWOT and Corporate Finance Report Summary Berliner Volksbank eG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Monster Worldwide Inc:企業の戦略的SWOT分析
    Monster Worldwide Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • University of Illinois-製薬・医療分野:企業M&A・提携分析
    Summary University of Illinois (UOL) is a university that offers undergraduate, graduate, and professional programs. The university offers online and continuing education programs such as undergraduate and graduate online degrees. It provides research activities in the areas of alternative, compleme …
  • The Great-West Life Assurance Co:電力:M&Aディール及び事業提携情報
    Summary The Great-West Life Assurance Co (Great-West Life), a subsidiary of Great-West Lifeco Inc., focuses on life insurance, health insurance, retirement savings, investments, and reinsurance businesses. For individuals, it offers life insurance, disability insurance, critical illness insurance, h …
  • Bracco SpA:企業の戦略的SWOT分析
    Bracco SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • C.H. Robinson Worldwide, Inc.:企業の戦略・SWOT・財務情報
    C.H. Robinson Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report Summary C.H. Robinson Worldwide, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • NTT DOCOMO Inc:企業の戦略・SWOT・財務分析
    NTT DOCOMO Inc - Strategy, SWOT and Corporate Finance Report Summary NTT DOCOMO Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Ford Motor Company:企業の戦略・SWOT・財務分析
    Ford Motor Company - Strategy, SWOT and Corporate Finance Report Summary Ford Motor Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • TechnipFMC Plc (FTI):企業の財務・戦略的SWOT分析
    TechnipFMC Plc (FTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Shanghai Institute of Materia Medica Chinese Academy of Sciences:製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Institute of Materia Medica Chinese Academy of Sciences (SIMM) is an educational research institute that provides research and development of traditional Chinese medicine. The institute offers solutions in the areas of drug discovery and drug development. It also offers studies of s …
  • SOCOMEC Group:企業の戦略的SWOT分析
    SOCOMEC Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Gebr. Heinemann SE & Co KG:企業の戦略・SWOT・財務分析
    Gebr. Heinemann SE & Co KG - Strategy, SWOT and Corporate Finance Report Summary Gebr. Heinemann SE & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Fortitech Inc.:戦略・SWOT・企業財務分析
    Fortitech Inc. - Strategy, SWOT and Corporate Finance Report Summary Fortitech Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • BOOM Logistics Ltd (BOL):企業の財務・戦略的SWOT分析
    BOOM Logistics Ltd (BOL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Institut Gustave Roussy-製薬・医療分野:企業M&A・提携分析
    Summary Institut Gustave Roussy (IGR) is a cancer research institute that offers healthcare services to patients suffering from cancer and conducts research to identify new therapies. The institute provides treatment for the diseases that include endocrine tumours, childhood cancer, gynecological ca …
  • Toshiba Corporation (6502)-エネルギー分野:企業M&A・提携分析
    Summary Toshiba Corporation (Toshiba) is an electronics, electrical equipment and information technology company. It offers digital consumer products such as LCD TV, Blue-ray disc servers, tablet and Note PC’s; electronic devices and components including solid-state drive NAND flash memory, hard dis …
  • Alchemia Ltd (ACL):製薬・医療:M&Aディール及び事業提携情報
    Summary Alchemia Ltd (Alchemia) is an early stage biopharmaceutical company that focuses on the discovery and development of drugs for the treatment of various diseases. It sold the worldwide exclusive intellectual property rights to its product, Fondaparinux sodium (a generic version of the anticoa …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆